OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

1,967 JAZZ shares were withheld to cover taxes or exercise cost (CEO) | OQRO

Home
Insider trades
Jazz Pharmaceuticals
1,967 JAZZ shares were withheld to cover taxes or exercise cost (CEO)

Insider trades

Insider trade

1,967 JAZZ shares were withheld to cover taxes or exercise cost (CEO)

Traded Sep 8, 2026 · Filed Sep 11, 2026

JAZJazz PharmaceuticalsJAZZ

1,967
Shares · @ $246.81

Why it stands out

Routine share withholding; mechanical by default.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Sep 8, 2026
Reporting period: Not applicable
Filed with the SEC: Sep 11, 2026

CEOTax withholding

Context

Classification

tax withholding

Code F — shares delivered to pay exercise price or tax liability

Planned / mechanical clue

Tax mechanics (code F)

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001607737-26-000013

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Sep 11, 2026, 12:33 AM UTC

Added to OQRO

Oct 6, 2026, 7:59 PM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

Jazz Pharmaceuticals plc

Issuer CIK

1232524

Ticker

JAZZ

Reporting person

Renee D Gala

Relationship

Officer

Officer title

President & CEO

Security

Ordinary Shares

Table

Non-derivative (Table I)

Transaction date

Sep 8, 2026

Transaction code

Shares / units

1,967

Price per share

$246.81

Acquired / disposed

Disposed (D)

Shares owned after

145,394

Ownership form

Direct

Amendment

Footnotes from the filing

Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units.

Around the same time

Director sold ~$1.38M of Jazz Pharmaceuticals

Scheduled in advanceyesterday

Officer sold ~$289K of Jazz Pharmaceuticals

Scheduled in advance3w ago

CEO sold ~$486K of Jazz Pharmaceuticals

Scheduled in advance4w ago